Docetaxel and Diethylstilbestrol in the Treatment of Androgen Independent Prostate Cancer
Status:
Completed
Trial end date:
2007-10-01
Target enrollment:
Participant gender:
Summary
This study is for men who have prostate cancer that has spread outside of the prostate gland
and is no longer responding to hormone removal therapy. This study is designed to determine
if a new drug combination will help to control the cancer. The medicines being used,
docetaxel and diethylstilbestrol (DES), have been given to patients with prostate cancer and
each drug has demonstrated activity in prostate cancer, either used alone or in other
combinations. The objective of this study is to determine the effect of this drug combination
on the prostate cancer and its response to disease progression.